The alkyl chain length of 3-alkyl-3',4',5,7-tetrahydroxyflavones modulates effective inhibition of oxidative damage in biological systems: illustration with LDL, red blood cells and human skin keratinocytes.
It is shown that the relationship between the alkyl chain length of 3-alkyl-3',4',5,7 tetrahydroxyflavones (FnH) bearing alkyl chains of n=1, 4, 6, 10 carbons and their capacity to counter oxidative damage varies markedly with the nature of the biological system. In Cu(2+)-induced lipid peroxidation of low-density lipoprotein (LDL), the less hydrophobic short-chain F1H and F4H are probably located in the outer layer of LDL and parallel the reference flavonoid antioxidant, quercetin (Q) as effective inhibitors of lipid peroxidation. A marked inhibition of haemolysis induced in red blood cells (RBC) suspensions by the membrane-permeant oxidant, tert-butylhydroperoxide (t-BuOOH), is observed with F4H and F6H present at concentration in the micromolar range. However, F10H the most hydrophobic FnH is even more effective than Q against both haemolysis and lipid peroxidation as measured by malondialdehyde (MDA) equivalents. In oxidation of RBC by H(2)O(2,) at least 50 times more F6H and F10H than by t-BuOOH are required to only partly inhibit haemolysis and MDA production. The F1H, F4H and Q are found rather inactive under these conditions. At concentrations in the micromolar range, a marked protection against the cytotoxic effects of the t-BuOOH-induced oxidative stress in human skin NCTC 2544 keratinocytes is also exhibited by the four FnH antioxidants and is comparable to that of Q. Thus, the four FnH species under study may be considered as potent antioxidants which manifest complementary anti-oxidative actions in biological systems of markedly different complexity.
Filipe
Paulo
P
Faculdade de Medicina de Lisboa, Clínica de Dermatologia, 1699 Lisboa, Portugal.
Silva
Artur M S
AM
Seixas
Raquel S G R
RS
Pinto
Diana C G A
DC
Santos
Alvaro
A
Patterson
Larry K
LK
Silva
João N
JN
Cavaleiro
José A S
JA
Freitas
João P
JP
Mazière
Jean-Claude
JC
Santus
René
R
Morlière
Patrice
P
D000975:Antioxidants / Q000737:chemistry* / Q000494:pharmacology*; D002461:Cell Line, Transformed; D003300:Copper / Q000502:physiology; D004912:Erythrocytes / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D015603:Keratinocytes / Q000187:drug effects* / Q000378:metabolism; D015227:Lipid Peroxidation / Q000187:drug effects / Q000502:physiology; D008077:Lipoproteins, LDL / Q000097:blood*; D047311:Luteolin / Q000737:chemistry* / Q000494:pharmacology*; D008954:Models, Biological; D010084:Oxidation-Reduction / Q000187:drug effects; D018384:Oxidative Stress / Q000187:drug effects* / Q000502:physiology; D017382:Reactive Oxygen Species / Q000378:metabolism
D000975:Antioxidants; D008077:Lipoproteins, LDL; D017382:Reactive Oxygen Species; D003300:Copper; D047311:Luteolin